Alger Mid Cap Focus Fund Class I
Not enough financial coverage to compute a composite score for AFOIX. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.alger.com/Pages/Products.aspx?productCode=5040
Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of mid-cap companies. In addition, under normal market conditions, it invests at least 25% of its total assets in companies in the following group of industries: Health Care Equipment & Supplies, Health Care Technology, Biotechnology, Life Sciences Tools & Services, and/or Software, as defined by third party sources. The fund may have 25% or more of its total assets invested in any one of these industries.
- IPO
- 2019
- HQ
- New York, NY, US
Price Chart
Performance & Tape
- 52W High
- $21.69
- 52W Low
- $16.64
- 50D MA
- $20.00
- 200D MA
- $20.35
- Beta
- 1.35
- Avg Volume
- 0
Get TickerSpark's AI analysis on AFOIX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our AFOIX Coverage
We haven't published any research on AFOIX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AFOIX Report →